Literature DB >> 28871807

Visualizing Carotid Bodies With Doppler Ultrasound Versus CT Angiography: Preliminary Study.

Dominik Swieton1, Mariusz Kaszubowski2, Anna Szyndler3, Marzena Chrostowska3, Krzysztof Narkiewicz3, Edyta Szurowska1, Zoar Engelman4, Maciej Piskunowicz1.   

Abstract

OBJECTIVE: The purpose of this article is to evaluate the utility of ultrasound in identifying carotid bodies (CBs) in patients with drug-resistant arterial hypertension. SUBJECTS AND METHODS: We enrolled 13 patients with drug-resistant hypertension into a trial for surgical CB excision. CT angiography (CTA) and Doppler ultrasound (DUS) of the cervical arteries were performed before surgery. CBs were identified in a blind manner at both CTA and DUS. CBs were defined at CTA as ovoid avidly enhancing structures at the inferomedial aspect of the carotid bifurcation. At DUS, CBs were defined as ovoid solid structures in the inferomedial aspect of the bifurcation.
RESULTS: CBs were identified in 12 of 13 patients (23/26 sides) using CTA and in 11 of 13 patients (18/26 sides) using DUS. Identification of CB with DUS and CTA correlated in 17 of 18 cases; in one instance, CB was identified with DUS but not CTA. There was no statistically significant difference in size and volume of CB measured by both methods.
CONCLUSION: Noncarcinogenic CBs can be visualized using DUS, with good correlation of size and location compared with CTA. The findings show that DUS can be reliably used to further examine the role of CBs in cardiovascular disorders and can be used in conjunction with therapies that target CBs.

Entities:  

Keywords:  CT angiography; carotid bodies; ultrasound

Mesh:

Year:  2017        PMID: 28871807     DOI: 10.2214/AJR.17.18079

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  1 in total

1.  Precision Targeted Ablation of Fine Neurovascular Structures In Vivo Using Dual-mode Ultrasound Arrays.

Authors:  Rajagopal N Aravalli; Dusty Van Helden; Dalong Liu; Parker O'Brien; Hasan Aldiabat; Alexandru-Flaviu Tăbăran; M Gerard O'Sullivan; H Brent Clark; John W Osborn; Emad S Ebbini
Journal:  Sci Rep       Date:  2020-06-08       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.